Computational network biology: data, models, and applications

C Liu, Y Ma, J Zhao, R Nussinov, YC Zhang, F Cheng… - Physics Reports, 2020 - Elsevier
Biological entities are involved in intricate and complex interactions, in which uncovering the
biological information from the network concepts are of great significance. Benefiting from …

In silico polypharmacology of natural products

J Fang, C Liu, Q Wang, P Lin… - Briefings in bioinformatics, 2018 - academic.oup.com
Natural products with polypharmacological profiles have demonstrated promise as novel
therapeutics for various complex diseases, including cancer. Currently, many gaps exist in …

Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Y Zhou, Y Hou, J Shen, Y Huang, W Martin, F Cheng - Cell discovery, 2020 - nature.com
Human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus
(SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also known as SARS-CoV-2), lead …

A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data

Y Li, K Kang, JM Krahn, N Croutwater, K Lee… - BMC genomics, 2017 - Springer
Abstract Background The Cancer Genome Atlas (TCGA) has generated comprehensive
molecular profiles. We aim to identify a set of genes whose expression patterns can …

Escape artists of the X chromosome

BP Balaton, CJ Brown - Trends in Genetics, 2016 - cell.com
Inactivation of one X chromosome in mammalian females achieves dosage compensation
between XX females and XY males; however, over 15% of human X-linked genes continue …

Precision medicine and driver mutations: computational methods, functional assays and conformational principles for interpreting cancer drivers

R Nussinov, H Jang, CJ Tsai… - PLoS computational …, 2019 - journals.plos.org
At the root of the so-called precision medicine or precision oncology, which is our focus
here, is the hypothesis that cancer treatment would be considerably better if therapies were …

BCL6 is regulated by the MAPK/ELK1 axis and promotes KRAS-driven lung cancer

K Li, Y Liu, Y Ding, Z Zhang, J Feng… - The Journal of …, 2022 - Am Soc Clin Investig
Mutational activation of KRAS is a common oncogenic event in lung cancer, yet effective
therapies are still lacking. Here, we identify B cell lymphoma 6 (BCL6) as a lynchpin in …

Vital node identification in hypergraphs via gravity model

X **e, X Zhan, Z Zhang, C Liu - Chaos: An Interdisciplinary Journal of …, 2023 - pubs.aip.org
Hypergraphs that can depict interactions beyond pairwise edges have emerged as an
appropriate representation for modeling polyadic relations in complex systems. With the …

[HTML][HTML] Medulloblastoma: molecular classification-based personal therapeutics

TC Archer, EL Mahoney, SL Pomeroy - Neurotherapeutics, 2017 - Elsevier
Recent advances in cancer genomics have revealed 4 distinct subgroups of
medulloblastomas, each with unique transcription profiles, DNA alterations and clinical …

When the Lyon (ized chromosome) roars: ongoing expression from an inactive X chromosome

L Carrel, CJ Brown - … Transactions of the Royal Society B …, 2017 - royalsocietypublishing.org
A tribute to Mary Lyon was held in October 2016. Many remarked about Lyon's foresight
regarding many intricacies of the X-chromosome inactivation process. One such example is …